Assoc. prof. Michal Chovanec, MD, PhD.
Research/art/teacher profile of a person
The most significant research/artistic/other outputs:
1. | Chovanec M, Hanna N, Cary KC, Einhorn L, Albany C. Management of stage I testicular germ cell tumours. Nature Reviews Urology. 2016 | Q1 | IF 7,735 |
2. | Chovanec M, Abu Zaid M, Hanna N, El-Kouri N, Einhorn LH, Albany C. Long-term toxicity of cisplatin in germ-cell tumor survivors. Annals of Oncology. 2017 | Q1 | IF 13,926 |
3. | Chovanec M, Vasilkova L, Setteyova L, Obertova J, Palacka P, Rejlekova K, Sycova-Mila Z, Kalavska K, Svetlovska D, Cingelova S, Mladosievicova B, Mardiak J, Mego M. Long-Term Cognitive Functioning in Testicular Germ-Cell Tumor Survivors. Oncologist. 2018 | Q2 | IF 5,252 |
4. | Chovanec M, Cierna Z, Miskovska V, Machalekova K, Kalavska K, Rejlekova K, Svetlovska D, Macak D, Spanik S, Kajo K, Babal P, De Giorgi U, Mego M, Mardiak J. Systemic immune-inflammation index in germ-cell tumours. British Journal of Cancer. 2018 | Q1 | IF 5,416 |
5. | Chovanec M, Lauritsen J, Bandak M, Oing C, Kier GG, Kreiberg M, Rosenvilde J, Wagner T, Bokemeyer C, Daugaard G. Late adverse effects and quality of life in survivors of testicular germ cell tumour. Nature Reviews Urology. 2021 | Q1 | IF 14,432 |